MLH1 and Lynch syndrome: Patients with tumor MMR-deficiency without evidence of a germline pathogenic variant or tumor MLH1 methylation are given a diagnosis of suspected Lynch syndrome/Lynch-like syndrome, also referred to as unexplained tumor MMR-deficiency, therefore, the patient (ID_151-1) was diagnosed with suspected Lynch syndrome.